Welcome to ASGCT: Who We Are and What We Do ASGCT

5.6K views - 7 years ago

Lunch & Learn: Annual Meeting Research Highlights ASGCT

848 views - 3 years ago

Mavis Agbandje-McKenna, Ph.D. – 2020 ASGCT Outstanding Achievement Award Lecture ASGCT

1K views - 5 years ago

Potential Challenges Throughout the Development Process ASGCT

305 views - 6 years ago

Adaptimmune ASGCT 2021 US WorldMeds

1.2K views - 4 years ago

Intro ...

Lunch & Learn: Gene Therapy 101 ASGCT

44.2K views - 4 years ago

ASGCT 2021 Presidential Symposium: Robert L. Martuza, M.D. ASGCT

470 views - 4 years ago

The Challenge to Develop and Commercialize Gene-Based Therapies for Rare Diseases ASGCT

392 views - 7 years ago

2020 ASGCT - Bringing Life to Gene and Cell Therapy R&D Benchling

152 views - 4 years ago

On the Brink of a Treatment Revolution for Inherited Pediatric Neurological Diseases ASGCT

354 views - 6 years ago

Cracking the Code of Payload Delivery in CGT Bio2Bedside

3 views - 5 months ago

Dissecting and Overcoming Innate Immune Barriers for Efficient Stem Cell Gene Engineering ASGCT

258 views - 6 years ago

What to Expect as a Participant in a Gene Therapy Clinical Trial ASGCT

1.4K views - 3 years ago

SPEAR T-cells Derived from Stem Cells Kill Cancer Targets in vitro - data from ASGCT 2020 US WorldMeds

1.8K views - 5 years ago

Gene Therapy Targets and Biomarkers: Molecular Therapy Presents ASGCT

720 views - 1 year ago

Trust, Innovation, and the Power of Patient Advocacy with Brendan Hayes - ASGCT's The Issue ASGCT

116 views - 1 year ago

FDA's Programs to Promote Patient Access to Investigational Therapies ASGCT

130 views - 6 years ago

Cell Therapeutics for Pulmonary Disease - Daniel Weiss ASGCT

165 views - 7 years ago

Gene Therapy for Inherited Retinal Diseases ASGCT

44.5K views - 7 years ago

Blood Cancers and CAR T-Cell Therapy ASGCT

7.2K views - 6 years ago